摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-二氯-3-羟基喹啉-2(1h)-酮 | 176170-12-0

中文名称
5,7-二氯-3-羟基喹啉-2(1h)-酮
中文别名
——
英文名称
5,7-dichloro-3-hydroxyquinolin-2(1H)-one
英文别名
5,7-dichloro-3-hydroxy-1H-quinolin-2-one
5,7-二氯-3-羟基喹啉-2(1h)-酮化学式
CAS
176170-12-0
化学式
C9H5Cl2NO2
mdl
——
分子量
230.05
InChiKey
BYQGONOAAITQHT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    456.2±45.0 °C(Predicted)
  • 密度:
    1.631±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933790090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,7-二氯-3-羟基喹啉-2(1h)-酮N-氯代丁二酰亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 4,5,7-trichloro-3-hydroxy-1H-quinolin-2-one
    参考文献:
    名称:
    3-Hydroxy-quinolin-2-ones: Inhibitors of [3H]-glycine binding to the site associated with the NMDA receptor
    摘要:
    A series of substituted 3-hydroxy-quinolin-2-one derivatives 6 was synthesized and evaluated as inhibitors of [H-3]-glycine and [H-3]-AMPA binding to rat cortical membranes. These compounds were generally found to be more potent ligands for the NMDA-associated glycine binding site than the AMPA receptor. Affinity for the glycine site was found to be influenced by both the electronic and steric properties associated with the C-4 substituent and the nature and pattern of substitution of the aromatic ring. The most active compound in this series, 6y, displaces [H-3]-glycine with an IC50 of 29 nM.
    DOI:
    10.1016/0960-894x(96)00031-5
  • 作为产物:
    描述:
    4,6-二氯靛红盐酸sodium hydroxide二乙胺 作用下, 以 乙醇甲苯 为溶剂, 生成 5,7-二氯-3-羟基喹啉-2(1h)-酮
    参考文献:
    名称:
    3-Hydroxy-quinolin-2-ones: Inhibitors of [3H]-glycine binding to the site associated with the NMDA receptor
    摘要:
    A series of substituted 3-hydroxy-quinolin-2-one derivatives 6 was synthesized and evaluated as inhibitors of [H-3]-glycine and [H-3]-AMPA binding to rat cortical membranes. These compounds were generally found to be more potent ligands for the NMDA-associated glycine binding site than the AMPA receptor. Affinity for the glycine site was found to be influenced by both the electronic and steric properties associated with the C-4 substituent and the nature and pattern of substitution of the aromatic ring. The most active compound in this series, 6y, displaces [H-3]-glycine with an IC50 of 29 nM.
    DOI:
    10.1016/0960-894x(96)00031-5
点击查看最新优质反应信息

文献信息

  • US5597922A
    申请人:——
    公开号:US5597922A
    公开(公告)日:1997-01-28
  • [EN] GLYCINE RECEPTOR ANTAGONIST PHARMACOPHORE<br/>[FR] PHARMACOPHORE D'ANTAGONISTES DU RECEPTEUR DE LA GLYCINE
    申请人:STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON
    公开号:WO1996004288A1
    公开(公告)日:1996-02-15
    (EN) Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotropic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions and inducing anesthesia are disclosed by administering to an animal in need of such treatment a compound which has high binding to the glycine receptor.(FR) L'invention se rapporte à des procédés de traitement ou de prévention de la perte neuronale associée à l'attaque, à l'ischémie, aux traumatismes du SNC (système nerveux central), à l'hypoglycémie et aux interventions chirurgicales, ainsi qu'au traitement des maladies dégénératives telles que la maladie d'Alzheimer, la sclérose latérale amyotrophique, la maladie de Huntington et le syndrome de Down, et au traitement ou à la prévention des conséquences fâcheuses de l'hyperactivité des acides aminés excitateurs, et au traitement de l'anxiété, de la douleur chronique, des convulsions et à l'induction d'une anesthésie. Ces procédés consistent à administrer à un animal nécessitant ce type de traitement un composé qui se lie fortement au récepteur de la glycine.
  • 3-Hydroxy-quinolin-2-ones: Inhibitors of [3H]-glycine binding to the site associated with the NMDA receptor
    作者:Sing-Yuen Sit、Frederick J. Ehrgott、Jinnian Gao、Nicholas A. Meanwell
    DOI:10.1016/0960-894x(96)00031-5
    日期:1996.3
    A series of substituted 3-hydroxy-quinolin-2-one derivatives 6 was synthesized and evaluated as inhibitors of [H-3]-glycine and [H-3]-AMPA binding to rat cortical membranes. These compounds were generally found to be more potent ligands for the NMDA-associated glycine binding site than the AMPA receptor. Affinity for the glycine site was found to be influenced by both the electronic and steric properties associated with the C-4 substituent and the nature and pattern of substitution of the aromatic ring. The most active compound in this series, 6y, displaces [H-3]-glycine with an IC50 of 29 nM.
查看更多